Document ID: chunk:federal_register_of_legislation:F2022L00012:reg:9:p1
Version: federal_register_of_legislation:F2022L00012
Segment Type: reg
Provision Reference: reg 9 (pt 1/3)
Character Range: 4231–7206

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the colon or rectum or death from malignant neoplasm of the colon or rectum with the circumstances of a person's relevant service:
(1)          having familial adenomatous polyposis before the clinical onset of malignant neoplasm of the colon or rectum;
(2)          having a colorectal adenoma involving the affected part of the colon or rectum before the clinical onset of malignant neoplasm of the colon or rectum;
(3)          being prevented from accessing clinical screening for colorectal precancerous lesions or colorectal cancer in accordance with contemporary medical standards of the time, within the 5 years before the clinical onset of malignant neoplasm of the colon or rectum, and:
(a)          if clinical screening has subsequently resumed, there has been no normal test result; and
(b)          the opportunity for subsequent clinical screening has not been declined;
Note: colorectal precancerous lesions is defined in the Schedule 1 - Dictionary.
(4)          being prevented from accessing appropriate treatment for colorectal precancerous lesions in accordance with contemporary medical standards of the time, within the 5 years before the clinical onset of malignant neoplasm of the colon or rectum;
Note: colorectal precancerous lesions is defined in the Schedule 1 - Dictionary.
(5)          having inflammatory bowel disease involving the colon or rectum for at least 3 years before the clinical onset of malignant neoplasm of the colon or rectum;
(6)          undergoing a course of therapeutic radiation for cancer, where the affected part of the colon or rectum was in the field of radiation, before the clinical onset of malignant neoplasm of the colon or rectum;
(7)          having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the colon or rectum at least 5 years before the clinical onset of malignant neoplasm of the colon or rectum;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(8)          inhaling respirable asbestos fibres in an enclosed space, at the time material containing asbestos was being applied, removed, cut, drilled, dislodged or disturbed:
(a)          for a cumulative period of at least 1,000 hours before the clinical onset of malignant neoplasm of the colon or rectum; and
(b)          where the first inhalation of asbestos fibres commenced at least 5 years before the clinical onset of malignant neoplasm of the colon or rectum;
            Note: Disturbance of debris or dust contaminated with asbestos fibres already present in an enclosed space may result in exposure to respirable asbestos fibres.
(9)          inhaling respirable asbestos fibres in an open environment, at the time material containing asbestos was being applied, removed,